Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration

Treatment options for people living with amyotrophic lateral sclerosis (ALS) are limited and ineffective. Recently, dexpramipexole (RPPX) was advanced into human ALS clinical trials. In the current studies, we investigated RPPX in two parallel screening systems: 1) appropriately powered, sibling-mat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Vieira, Fernando G., LaDow, Eva, Moreno, Andy, Kidd, Joshua D., Levine, Beth, Thompson, Kenneth, Gill, Alan, Finkbeiner, Steven, Perrin, Steven
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272269/
https://ncbi.nlm.nih.gov/pubmed/25526593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0091608
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk